The project has two objectives: (1) Increase citrus disease resistance by activating the NAD+-mediated defense-signaling pathway. (2) Engineer non-host resistance in citrus to control citrus canker and HLB. For objective 1, both soil drench and foliar spraying of NAD+ have been performed. In the side-by-side experiment with the plant defense activator Actogard, soil drench provided good protection against citrus canker, whereas foliar spraying had limited effects. We are repeating the experiment and trying to find the best approach for NAD+ application. We have also been testing NAD+ analogs to identify potential chemicals for citrus disease control. For objective 2, newly generated transgenic plants are growing in greenhouse. Presence and expression of the transgenes have been tested. All transgenic plants are growing in the greenhouse and will be tested for canker resistance. Citrus homologs of the defense genes have been cloned and sequenced. The will be used for functionality test through complementation experiment.
All of the research described in the previous report is still ongoing or is still being analyzed. The one year study of the in vivo tracking of FT1, FT2, and FT3 in various citrus trees differing in age and phenotype is concluded and is being analyzed. A study of CiFT3 transgenic tobacco plants treated with various growth regulators has been performed and all of the data have been collected except for the flowering dates of the nontransgenic control plants that have not yet flowered. The growth hormones produced striking and individually different phenotypes in each treatment. The data includes plant height and leaf number, size, and area. The endogenous ciFT3 promoter from sweet orange was successfully cloned to be used in the transcription activator-like (TAL) effector system inducible by methoxyfenozide that will hopefully activate the naturally present FT3 gene in citrus. The complete construct is completed and is being tested in tobacco for a rapid test before citrus experiments are started. This research was presented at the ASHS national meeting.
The objectives of this project are: 1) to generate transcriptome profiles of both susceptible and resistant citrus responding to HLB infection using RNA-Seq technology; 2) to identify key resistant genes from differentially expressed genes and gene clusters between the HLB-susceptible and HLB-resistant plants via intensive bioinformatics and other experimental verifications; and 3) to create transgenic citrus cultivars with new constructs containing the resistant genes. A total of 25 samples for RNA-Seq, including resistant/tolerant vs. susceptible plants were sequenced and analyzed. We mapped the RNA-Seq data to a reference genome, C. clementina using the bioinformatics program STAR. About 85% of the raw reads could be uniquely mapped. The transfrags of each library were assembled with cufflinks and merged with cuffmerg. 24,275 genes of the originally predicted genes had been found to be expressed and a total of 10,539 novel transfrags were identified with cufflinks, which were missing from the original reference genome annotation. Some of the NBS genes were found to be expressed. For C. clementine and C. sinensis, there were 118,381 and 214,858 mRNAs or ESTs deposited in GenBank and 93 out of 607 and 221 out of 484 NBS related genes match one or more ESTs respectively. The number of ESTs varied from 1 to 25. The expression abundance of each gene was measured by FPKM. The distribution curves of density of FPKM of 6 samples are very similar, indicating that the gene expression is similar and the quality of sequencing is high. We also performed the principal component (PC) analysis study on the expressions of six samples. The results showed that the gene expressions were significantly different in resistant vs. susceptible citrus. A total of 686 differentially expressed (DE) genes between two groups using FDR threshold of 0.1 were identified. Among them, 247 genes were up-regulated and 439 were down-regulated in tolerant citrus trees. We performed Gene Ontology (GO) enrichment analysis of DE genes. Genes associated with beta-amyrin synthase, cycloartenol synthase and Camelliol C synthase were significantly up-regulated in the HLB tolerant citrus trees while terpene synthase genes (CiClev10014707, Ciclev10017785) were down-regulated in the tolerant citrus trees. Some PR-protein genes were significantly up-regulated in the resistant citrus trees, including several TIR-NBS-LRR genes. Many cell wall degradation-related genes, such as cellulose synthase/transferase, cellulase and expansins were up-regulated in the susceptible citrus trees. Some glucan hydrolase genes were also up-regulated in the resistant citrus trees. These genes may play important roles in symptom development. The DE genes were also enriched in two classes of RLKs, LRR-RLKs and DUF26-RLKs. We have experimentally verified the expressions of 14 up-regulated genes and 20 down-regulated genes on three HLB-tolerant ‘Jackson’ and three HLB-susceptible ‘Marsh’ trees using real time PCR. 11 of 14 up-regulated genes and 18 of 20 down-regulated genes were validated. Further characterization is underway for these differentially expressed genes and their potential roles in HLB progression. Meanwhile we are making constructs of a few selected genes for citrus transformation.
We continued to computationally analyze genomes with the goal to suggest hypotheses about molecular mechanisms of Liberibacter pathogenicity. We added the genome of Liberibacter solanacearum (CLso-ZC1, 1192 proteins) to the analysis of Liberibacter americanus (Sao Paulo, PW_SP, 983 proteins), Liberibacter asiaticus (gxpsy, psy62, A4,1109 proteins), and Liberibacter crescens: (BT-1, 1378 protiens). Similarly to other Liberibacter, solanacearum genome contains 2 prophages, but they are not arranged in tandem. One of the prophages is highly similar, in agreement with the hypothesis that prophage proteins and their homologs integrated in the Liberibacter genome may be the cause of pathogenicity. Prophages of culturable (and possibly non-pathogenic or less pathogenic) L. crescens are less similar to those of other species. Comparative analysis of the genomes identified about 70 potential pathogenicity genes. 40% of them have homologs in the prophage region. Many contain predicted signal peptides, suggesting that they are exported. Some of these proteins are not of bacterial origin, but are more similar to Eukaryotic proteins, additionally reinforcing the evidence for their hypothesized pathogenicity. Some of the highlights are mentioned here. Hypothetical protein CLIBASIA 3975 is homologous to Protein tyrosine phosphatase (PTPc), which is a Eukaryotic protein not needed in Bacteria that functions in numerous eukaryotic signalling pathways. These phosphates are frequently exploited by pathogenic bacteria for virulence. In addition, CLIBASIA 3975 possesses a signal peptide and is expected to be a secreted protein. Hypothetical protein CLIBASIA 3630 is homologous to Von Willebrand factor type A (vWFA), a mainly extracellular eukaryotic domain that functions in immune defenses. vWFA in the pilus of a Streptococcal pathogen mediates adhesion to host cells, so it is likely that this protein is one of the pathogenicity factors. CLIBASIA 3975 also has a pilus domain TadG. Hypothetical protein CLIBASIA 1935 is similar to OmlA protein from Xanthomonas axonopodis pv. citri. Since X. citri is a citrus canker pathogen and expression of OmlA is enhanced when grown on citrus leaves, this protein may be a potential virulence factor. In addition it has a predicted signal peptide, suggesting that it secreted. More distant homologs of this protein are from the ‘BLIP’ (b-Lactamase Inhibitor) Fold. There is a loop in the protein structure that is known to insert in lactamase active site and inhibit it. Similarly located loop is present in CLIBASIA 1935, suggesting that this protein may be an inhibitor or some enzyme from Citrus.
We have found that cell penetrating peptides (CPPs) can be used to deliver molecular ‘cargo’ (e.g. protein or DNA) into a variety of plant tissues, including those of citrus. However, to date, stable genetic transformation with CPPs but without the use of Agrobacterium-based DNA sequences has not been achieved in citrus. The Foundation wanted us to concentrate on this specific objective due to the considerable regulatory issues surrounding the use of such bacterial sequences in transgenic plants. Fortunately, since we began this project, there have been a number of new genetic developments. Targeted DNA modification, or ‘gene-editing’, methods such as Zinc Fingers and TALEN technology have been developed. However, the most recent and exciting developments have been with the CRISPR/Cas system. This system not only allows for very precise, targeted gene editing, but gene over-expression or repression is also possible. Further, the CRISPR/Cas system is simpler to engineer than other available systems, and less likely to have nonspecific binding or to recombine out. Finally, this methodology will satisfy the main objective, which should allow engineering of citrus without the use of inserted non-native (e.g. bacterial) DNA sequences. We hope that the CRISPR/Cas system will allow transgenic plants to be free from regulatory issues (although, the USDA still has this under consideration). This quarter, we have concentrated on designing CRISPR/Cas vectors for use with CPPs and citrus tissue. This is still underway.
Based on good field performance and superior yield with severe HLB infection pressure on the east coast, the rootstocks US-1279, US-1281, US-1282, US-1283, and US-1284 were released by USDA for commercial use. Fruit yield of Hamlin trees on these rootstocks is 2-4 times the yield of trees on Swingle in the same trials, and the trees also have fruit that is larger in size and higher in sugar content. These promising new rootstock selections have been provided to Florida DPI for establishment of certified budwood sources, are being made available to the CRDF Product Development Project to establish large scale commercial field trials, and will also be used in multiple field trials with commercial growers with funding provided by the HLB-MAC project. A special permit has been obtained from Florida DPI to immediately begin establishing widespread commercial field trials using clean USDA sources of these and other new rootstocks. Based on this permit, cooperative arrangements are being made with commercial Florida nurseries for large scale vegetative propagation of these promising new rootstocks, as needed to meet commercial demand until adequate seed sources can be developed. A material transfer agreement was signed with Agromillora Catalana, SA, to immediately allow that company to begin rapid micropropagation of these most promising rootstock selections for use in Florida. Trees were prepared for planting of three new field trials with Supersour rootstocks later in 2014. About ten thousand new propagations of Supersour rootstocks were prepared for budding and planting in additional field trials in 2015. Work began to construct an additional greenhouse at USDA to propagate Supersour rootstocks for field trials. Cooperative work continued with a commercial nursery to multiply promising Supersour rootstocks to produce trees for medium-scale commercial trials. A Valencia field trial was planted with a commercial cooperator to evaluate performance of several promising Supersour rootstock selections alongside other good commercial rootstocks. Greenhouse studies continued to assess Supersour tolerance of CTV, calcareous soils, and salinity. Trees were planted into the field to establish seed sources for the most promising Supersour selections. A study of the interaction between rootstock tolerance and scion tolerance/susceptibility will be presented at the HLB conference in February and is being prepared for publication. This work provides considerable insight into disease progression and the potential for improved management. Studies continued on defense-related genes and small RNAs associated with HLB infection, in collaboration with University of Maryland and University of California research groups. A study of localized defense gene expression in shoots and roots provided evidence of striking differences that are a major advance in understanding and yield strong insights into ways to overcome the disease. A new field trial was planted to evaluate grafting height effect on tree tolerance to HLB. Two replicated tests with US-942 rootstocks that overexpress the citrus defense gene CtNDR1, are showing significant reduction in Las infection for some of the transformed clones. Monitoring and data collection continued on previous groups of transgenic plants that have been inoculated with HLB. Several transgenic rootstock selections showing increased resistance to HLB have been identified from groups transformed with other resistance genes, and are also being prepared for confirmation testing. One hundred new transgenic US-942 and Sour orange rootstocks were produced, targeting to increase tolerance to HLB by manipulation of the citrus resistance genes CtNHL3, CtNHO1, CtDIR1, CtAZL1, CtERF1, and CtFMO1.
USDA-ARS-USHRL, Fort Pierce Florida is producing thousands of scion or rootstock plants transformed to express peptides that might mitigate HLB. The more rapidly this germplasm can be evaluated, the sooner we will be able to identify transgenic strategies for controlling HLB. The purpose of this project is to support a high-throughput facility to evaluate transgenic citrus for HLB-resistance. This screening program supports two USHRL projects funded by CRDF for transforming citrus. Non-transgenic citrus can also be subjected to the screening program. CRDF funds are being used for the inoculation steps of the program. Briefly, individual plants are caged with infected psyllids for two weeks, and then housed for six months in a greenhouse with an open infestation of infected psyllids. Plants are then moved into a psyllid-free greenhouse and evaluated for growth, HLB-symptoms and Las titer. USDA-ARS is providing approximately $18,000 worth of PCR-testing annually to track CLas levels in psyllids and rearing plants. Additionally, steps to manage pest problems (spider mites, thrips and other unwanted insects) are costing an additional $1,400 annually for applications of M-Pede and Tetrasan and releases of beneficial insects. To date on this project, it funds a technician dedicated to the project, a career technician has been assigned part-time (~50%) to oversee all aspects of the project, two small air-conditioned greenhouses for rearing psyllids are in use, and 18 individual CLas-infected ACP colonies located in these houses are being used for caged infestations. Additionally, we established new colonies in a walk-in chamber at USHRL to supplement production of hot ACP. Some of the individual colonies are maintained on CLas-infected lemon plants while others are maintained on CLas-infected Citron plants. As of September 2, 2014, a total of 6,208 transgenic plants have passed through inoculation process. A total of 122,855 bacteriliferous psyllids have been used in no-choice inoculations.
A transgenic test site at the USDA/ARS USHRL Picos Farm in Ft. Pierce supports HLB/ACP/Citrus Canker resistance screening for the citrus research community. There are numerous experiments in place at this site where HLB, ACP, and citrus canker are widespread. The first trees have been in place for over four years. Dr. Jude Grosser of UF has provided ~600 transgenic citrus plants expressing genes expected to provide HLB/canker resistance, which have been planted in the test site. Dr. Grosser planted an additional group of trees including preinoculated trees of sweet orange on a complex tetraploid rootstock that appeared to confer HLB resistance in an earlier test. Dr. Kim Bowman has planted several hundred rootstock genotypes, and Ed Stover 50 sweet oranges (400 trees due to replication) transformed with the antimicrobial peptide D4E1. Texas A&M Anti-ACP transgenics produced by Erik Mirkov and expressing the snow-drop Lectin (to suppress ACP) have been planted along with 150 sweet orange transgenics from USDA expressing the garlic lectin. More than 120 citranges, from a well-characterized mapping population, and other trifoliate hybrids (+ sweet orange standards) have been planted in a replicated trial in collaboration with Fred Gmitter of UF and Mikeal Roose of UCRiverside. Plants are being monitored for CLas development and HLB symptoms. Data from this trial should provide information on markers and perhaps genes associated with HLB resistance, for use in transgenic and conventional breeding. Dr. Roose has completed initial genotyping on a sample of the test material using a “genotyping by sequencing” approach. So far, the 1/8th poncirus hybrid nicknamed Gnarlyglo is growing extraordinarily well. It is being used aggressively as a parent in conventional breeding. In a project led by Richard Lee, an array of seedlings from the Germplasm Repository are in place, with half preinoculated with Liberibacter. Additional plantings are welcome from the research community.
A chimeral construct that should enhance AMP effectiveness (designed by Goutam Gupta of Los Alamos National Lab) is being tested. Many transformed Carrizo with the chimera AMP were obtained. Exposure to canker inoculum showed remarkabe resistance in chimera compared to control. Canker infiltration showed greatly increased resistance in two chimera AMP and several thionin transgenics, at 107CFU/ml. RNA was isolated from transgenic plants containing chimera and thionin. RT-PCR showed gene expression in the transgenic plants. Further gene expression level was evaluated with RT-qPCR. Our results showed gene expression variation between different transgenic lines, from several fold to 35 fold. Transgenic lines containing D4E1 were evaluated with Xcc infiltration. All the transgenic lines with canker development at 105 CFU/ml while some transgenic lines show less canker development at 104 CFU/ml. Bacterial growth rate in transgenic lines containing D4E1, chimera and thionin was investigated by qPCR. Our results showed some transgenic lines containing chimera and thionin had low Xcc growth rate. More transformed Hamlin carrying chimera were generated and over 30 were confirmed positive by PCR. About 20 Hamlin transformed with thionin also were obtained. They will be tested by RT-PCR and replicated for HLB challenge. Putative transgenic plants of PP-2 hairpins (for suppression of PP-2 through RNAi to test possible reduction in vascular blockage even when CLas is present) and of PP-2 directly are grafted in the greenhouse and growing for transgene verification, replication and testing. 40 putative transgenic plants transformed with citGRP1 were tested by PCR and twenty two of them were confirmed with citGRP1 insertion. RNA was isolated from some and RT-PCR showed gene expression. Some transgenics with over-expression of citGRP1 had increased resistance to canker by detached leaf assay and infiltration with Xanthomonas. Over 60 transgenic Carrizo with GRP2 were transferred to soil. DNA was isolated from 20 of them and 19 of them are PCR positive. Some of them showed canker resistance when infiltrated with Xcc at concentration of 105/CFU. Fifteen transgenic Carrizo and seven transgenic Hamlin with peach dormancy related gene MADS6 were planted in soil and they are ready for DNA isolation. To explore broad spectrum resistance, a flagellin receptor gene FLS2 from tobacco was cloned into pBinARSplus vector Flagellins are frequently PAMPS (pathogenesis associated molecular patterns) in disease systems and CLas has a full flagellin gene despite having no flagella detected to date. The consensus FLS2 clone was obtained and used to transform Hamlin and Carrizo so that resistance transduction may be enhanced in citrus for HLB and other diseases. Many putative transformants were generated on the selective media. DNA was isolated from 80 of them: 38 Carrizo and 7 Hamlin are positive by PCR test. Reactive Oxygen Species (ROS) assay showed typical ROS reaction in three of transgenic Hamlin which suggest nbFLS is functional in citrus PAMP-triggered immunity. However, there is only slight canker resistance by infiltration test. Spray inoculation was tried and some of them show obvious canker resistance. To disrupt HLB development by manipulating Las pathogenesis, a luxI homolog potentially producing a ligand to bind LuxR in Las was cloned into binary vector and transformed citrus. Both transformed Carrizo and Hamlin were obtained. Further investigation are underway. A series of transgenics scions produced in the last several years continue to move forward in the testing pipeline. Several D35S::D4E1 sweet oranges show initial growth in the field which exceeds that of controls. A large number of ubiquitin::D4E1 and WDV::D4E1 plants and smaller numbers with other AMPs are replicated and in early stages of testing.
We have found that cell penetrating peptides (CPPs) can be used to deliver molecular ‘cargo’ (e.g. protein or DNA) into a variety of plant tissues, including those of citrus. However, to date, stable genetic transformation with CPPs but without the use of Agrobacterium-based DNA sequences has not been achieved in citrus. The Foundation wanted us to concentrate on this specific objective due to the considerable regulatory issues surrounding the use of such bacterial sequences in transgenic plants. Fortunately, since we began this project, there have been a number of new genetic developments. Targeted DNA modification, or ‘gene-editing’, methods such as Zinc Fingers and TALEN technology have been developed. However, the most recent and exciting developments have been with the CRISPR/Cas system. This system not only allows for very precise, targeted gene editing, but gene over-expression or repression is also possible. Further, the CRISPR/Cas system is simpler to engineer than other available systems, and less likely to have nonspecific binding or to recombine out. Finally, this methodology will satisfy the main objective, which should allow engineering of citrus without the use of inserted non-native (e.g. bacterial) DNA sequences. We hope that the CRISPR/Cas system will allow transgenic plants to be free from regulatory issues (although, the USDA still has this under consideration). This quarter, we have concentrated on designing CRISPR/Cas vectors for use with CPPs and citrus tissue. This is still underway.
This quarter we have continued to make progress on our transformation approaches: 1. Stable transformation in citrus using new vectors. We previously found that the original vector system used to create the Bs3 promoter constructs was contributing to low transformation efficiency in citrus, and switched to a pCAMBIA-based vector system. Two ProBs314EBE:avrGf2 transgenic plants created using the new vectors in citrus cultivar Carrizo have now been confirmed by PCR to contain the transgene, and these will be examined for appropriate gene expression by RT-PCR. An ongoing pipeline of transformants are being generated with the new vectors. To date a total of 2,056 putative transgenic shoots of grapefruit, sweet orange and Carrizo were screened for this period. Results show that no GUS positive has been observed for the sweet orange cultivar transformed with any of the constructs analyzed, however, 3 shoots were chimeric for the pCAMBIA2201:NosT:Bs3super::avrGF2 construct. In general, Grapefruit had a combined total of 12 and 41 shoots being GUS positive and chimeric for GUS, respectively for all constructs anlayzed while Carrizo citrange had 185 and 180 shoots being GUS positive and chimeric for GUS, respectively. These GUS and chimeric shoots will later be screened via PCR once rooted and transferred to soil for acclimatization. 2. Stable transformation in tomato test system: A tomato test system was previously designed and tested in which the 14 EBE promoter was fused to the avrBs4 gene capable of inducing a hypersensitive reaction in tomato. T1 generation of Bonny Best and Large Red Cherry transformed with ProBs3_14EBE:avrBs4 were screened for pathogenicity reaction with X. euvesicatoria strain (Race 9). Promising resistant transgenics have been selected for T2 generation analysis to confirm that this test system, in which resistance is induced by the effectors AvrBs3 and AvrHah1, is functional for conferring stably-transformed transgenic disease resistance.
We are still working to obtain stably transformed citrus containing the BS3 promoter with added TAL effector binding elements (4 or 14 EBE) fused to a defense response inducing gene. We have obtained three transformants with a 14 EBE construct driving either the AvrGf1 or AvrGf2 Xanthomonas effector gene in Carrizo citrange, a citrus variety more amenable to transformation. PCR-based analysis of gene expression demonstrated that these constructs were induced as expected upon infection with the virulent strain X. citri strain Xcc306, validating that the promoter works in stably-transformed citrus. Whereas expression of AvrGf1 or 2 genes in orange and grapefruit triggers a hypersensitive defense response, this reaction doesn’t occur in Carrizo and we are not able to assess resistance to X. citri in these plants. In Duncan grapefruit, our efforts to transform constructs with AvrGf1 and AvrGf2 transgenes, where an inducible hypersensitive response is expected, have led to the isolation of seven putative transformants. These were sequenced to determine whether the transgene construct was intact. We found that all seven had deletions in the area of the transgene comprising parts of the promoter region and Avr gene. We believe our difficulty in obtaining transgenic grapefruit is arising either because the construct may have a tendency to recombine in Agrobacterium or during the transformation process, or the promoter may be leaky at some point during the transformation process, even though we have shown that it is tightly regulated in transient assays in leaves. Therefore, we are taking further steps to assess the stability and background expression of the construct. To investigate construct stability, transgenic tobacco plants (Nicotiana tabacum) resulting from the constructs pCAMBIA2201, pCAMBIA2201:NosT:Bs3super::avrGF2, and pCAMBIA2201:NosT:Bs34box::avrGF2 have been generated to determine whether the constructs are stable in another system. If construct sequence optimization is necessary, it will be easier in the tobacco system. We are also carefully assessing the potential for background expression of the construct. Four Carrizo transgenics containing the 14EBE construct fused to GUS were obtained, and these will be verified for the presence of the intact transgene by PCR, followed by GUS staining to determine whether there is any unexpected expression in any tissues other than leaves. In addition, N. tabacum and N. benthamiana transgenic plants carrying the 14 EBE construct fused to GUS will be stained to determine whether GUS is expressed anywhere in the plant. If one of the added EBEs produces unwanted background expression, we will be better able to determine which one is problematic in this system. We will also attempt to transform Duncan grapefruit with a construct containing the Bs3 promoter without any added EBEs, fused to an Avr gene or to GUS, to assess whether the unaltered promoter produces any background expression. Work also continues in the tomato model system, where one transgenic line carrying the disease resistance construct showed a reduction in symptoms in initial tests. T2 plants are being generated for further study.
Objective 1: Generate functional EFR variants (EFR+) recognizing both elf18-Xac and elf18-CLas. In order to perform screening on complex EFR mutant libraries required to discover mutants which respond to elf18-CLas ,we have been developing a FACS-based screen. To this end we have generated a number of reporter lines (using GFP) in both suspension cultures and transgenic Arabidopsis plants. The reporter lines are driven by the FRK1, WRKY30 and PER4 promoters. We have tested two PER4p:GFP cell suspension lines for responsiveness to elf18, and both of these give clear induction of the reporter gene following treatment. However, when protoplasts were produced of these lines, elf18 responsiveness was no longer observed. We are currently retesting these lines to ensure the buffer conditions and EFR expression is correct. In addition, plant and cell suspension lines transformed with FRK1p:GFP and WRKY30p:GFP are also in the process of being tested. In addition to the mutagenesis approach, we screened the Nordborg collection of Arabidopsis ecotypes for sensitivity to elf18-CLas or reciprocal chimeric peptides of elf18-Ecoli and elf18-CLas. Of this collection, none show ROS in response to either elf18-CLas or the chimeric peptides. We did observed one line (Se-0) which had enhanced response to the CLas-Ecoli-elf18 chimera. This chimera has some activity in Col-0, but only at high concentrations. Further testing of this ecotype revealed that it also enhanced ROS to elf18-Ecoli and to flg22, indicating that it was not a variant of EFR which was causing the enhanced ROS. Indeed the sequence of EFR from Se-0 contains no non-synonymous SNPs. We have been also investigating the possibility of targeting other PAMPs. To this end we conducted a bioinformatic comparison of known PAMPs with those in C. Liberibacter asiaticus. From these search we identified CSP22 (Felix & Boller, JBC 2003, 278:6201) as a potential candidate, since it is conserved in the sequence required for recognition. We are currently waiting for delivery of the CLas-CSP22 peptide to test. Objective 2. Generate functional XA21-EFR chimera (XA21-EFRchim) recognizing axYS22-Xac. These constructs have been constructed and tested and a manuscript is under revision. Objective 3: Generate transgenic citrus plants expressing both EFR+ and XA21-EFRchim. Transformation experiments are ongoing; to date, a total of 5,781 ‘Duncan’ grapefruit and 956 sweet orange segments have been collectively transformed with the constructs EFR, EFR-XA21, EFR-XA21-EFRchim and pCAMBIA2201 (empty vector control). A total of 580 and 219 grapefruit and sweet orange shoots, respectively, were transferred to rooting media. These shoots were first analyzed histochemically for GUS expression. The results show that collectively 6 grapefruit shoots were GUS positive with the constructs EFR-XA21, EFR-XA21-EFRchim and pCAMBIA2201 and 1 sweet orange shoot GUS positive with the construct EFR-XA21-EFRchim. Other grapefruit shoots (47) collectively stained partially (chimeric) for GUS with the constructs EFR, EFR-XA21, EFR-XA21-EFRchim and pCAMBIA2201, while 5 sweet orange shoots stained chimeric for GUS with the constructs EFR, EFR-XA21 and EFR-XA21-EFRchim. Chimeric shoots were those segments with less than 85% of blue staining.
Evaluation of existing standard and non-standard cultivars (‘Hamlin’, ‘Temple’, ‘Fallglo’, ‘Sugar Belle’, ‘Tango’, and ‘Ruby Red’) for HLB resistance/tolerance is complete. In August 2010, the plants were established at Pico’s farm in Ft. Pierce Fl. Data on the growth rate, disease severity, and Candidatus Liberibacter asiaticus (CLas) titer levels have been collected since April 2012. All trees exhibited symptoms of HLB and tested positive for CLas. During the 4-year period, there were significant differences in disease severity, stem diameter, and CLas levels among the varieties. ‘Fallglo’ had the lowest incidence of HLB symptoms, whereas ‘Ruby Red’ had the highest incidence. ‘Ruby Red’ also appears to be in significant decline. The highest CLas titer levels were observed in November, December, and January with ‘Sugar Belle’ and ‘Tango’ had the highest titer levels while ‘Fallglo’ and ‘Temple’ had the lowest. Despite the high titer levels found in ‘SugarBelle’, it had the greatest overall increase in diameter and was the healthiest in overall appearance. These results indicate that compared to ‘Hamlin’, ‘Fallglo’ and ‘Temple’ appear to display field resistance to HLB while ‘SugarBelle’ appears to have significant tolerance. Imidacloprid was applied quarterly to a subset of trees and significantly increased stem diameter compared to the non-treated trees but did not have a significant effect on tree height, disease severity, or CLas titer levels. Progress has been made on the antibiotic treatment of HLB infected bud-wood. Bud-wood of nine HLB symptomatic varieties, 3 fairly resistant (‘Temple’, GnarlyGlo’, and ‘Nova’) 3 tolerant (‘Jackson’, FF-5-51-2, and Ftp 6-17-48), and 3 susceptible (‘Flame’, ‘Valencia’, and ‘Murcott’). In November 2013 and May 2014, HLB positive bud-wood was treated with various concentrations of penicillin and streptomycin and grafted on sour orange rootstock. In August 2014, standard growth measurements (stem diameter and height), disease severity were evaluated and leaves were sampled for qPCR analysis. Evaluations and sampling will continue on quarterly basis. Development of periclinal chimeras with resistant vascular tissue from Poncirus and remaining layers from sweet orange is currently underway. One hundred and fifty etiolated seedlings of the trifoliate ‘Rubidoux’ and the sweet orange ‘Hamlin’ have been approach grafted together. Generation of new chimeras has been difficult. Several adventitious buds have emerged from the treated graft region, and one appears to be a chimera. The newly emerged plants will be tested using LC/MS to determine the origin of the three layers. To increase the success rate, additional plants will be grafted over the next twelve months. In October 2013, 34 unique genotypes (USDA hybrids) some of which appear to have tolerance to HLB, and 16 standard commercial varieties were exposed to an ACP no-choice feeding trial and have been transferred to the field at Ft. Pierce Fl. Standard growth measurements and disease ratings were initiated in July 2014 and will continue on a monthly basis. In September 2014 there were significant differences in trunk diameter (p<0.0001). At this time there were no significant differences in disease symptoms. However, it is still too early to assess for HLB resistance/tolerance. Three leaves were randomly samples and CLas titer levels will be quantified using qPCR. LC-MS assessment of potential HLB resistant biomarkers in Citrus and Citrus relatives is being explored. A method for the rapid identification of potential sources of HLB resistance is also being developed. This project involves the screening of citrus seedlings at the 3 to 5 leaf stage, or very small micrografted trees, that are exposed to HLB infect ACP feeding. CLas titer levels, using real time PCR, are evaluated at 3, 6, and 9 weeks Seedlings of Hamlin and Dancy show early CLas proliferation and systemic movement. Only very low levels of CLas have been observed in Carrizo.
The work in the Core Citrus Transformation Facility (CCTF) continued without interruption. Co-incubation experiments using different type of explants and Agrobacterium strains are still being done on a weekly basis resulting in production of more transgenic plants. Three new orders were received during the last three months although most of facility’s productivity came as result of work on older orders. Significant effort was invested into production of rootstock plants carrying the NPR1 gene requested by the CRDF. About 850 shoots were tested in the primary PCR with 135 of them being positive. Forty eight of these shoots died either before or after grafting, and 27 were negative in the second PCR. The other 60 positive shoots were grafted. Out of those, 27 were moved to pots. Presently, there are 29 plants in the greenhouse that are 6-10 inches tall. In about six weeks many of those plants will reach the size when they could be cut into nodal explants for propagation. In the period covered by this report, CCTF produced plants for the following orders: pNPR1-30 plants, pNPR1-G-five plants, pX4- two plants, pELP3-G-one plant, pELP4-G- one plant, pMG105- eight plants, pPR2-one plant, pHGJ2- one plant, pHGJ8-one plant, pW14- two plants, pMED16-four plants, pN7-three plants, pN18- four plants. Out of total of 63 transgenic plants, 29 were Carrizo citrange, three were Swingle citrumelo, one was C. macrophylla, one was Mexican lime, one was Valencia orange, and 28 were Duncan grapefruit. Within previous year the efficiency of transformation and the ability of explants to regenerate shoots are little lower than they were in previous years. The reason for this is probably the low quality of seedling explants which are starting material in our experiments. Seeds used for production of Duncan grapefruit, Valencia orange, and Hamlin orange seedlings that are cut into explants are obtained from fruit harvested on CREC property where HLB is widespread. Fruit have unhealthy appearance; seeds are smaller and have altered color. Seed vivipary which occurs in older fruit of Duncan appears four months earlier than it used to. This is a strong indicator of disrupted hormonal balance within the fruit which may contribute to changes we noticed. For this reason, we intend to change the way fruit are acquired. Duncan grapefruit will be picked from CREC property only between September and January. Depending on the quality of fruit this season CCTF may start getting Duncan fruit from the outside source even before January. Fruits of sweet oranges will be acquired from the outside sources throughout the whole season and CCTF will require assistance for this.
(863) 956-8817
(863) 956-5894
700 Experiment Station Road
Lake Alfred, FL 33850
Email Us
